Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
44
WST Quote, Financials, Valuation and Earnings
Last price:
$276.85
Seasonality move
:
6.23%
Day range:
$275.68 - $279.01
52-week range:
$187.43 - $348.90
Dividend yield:
0.31%
P/E ratio:
41.10x
P/S ratio:
6.70x
P/B ratio:
6.54x
Volume:
688.6K
Avg. volume:
700.2K
1-year change:
-16.86%
Market cap:
$20B
Revenue:
$2.9B
EPS (TTM):
$6.75
Earnings Data
Next earnings date for WST
Feb 12
2026
Most recent earnings per share
$1.93
Beat by $0.22
(Oct 23/2025)
Consensus Estimate
$1.71
(Oct 23/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WST Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $795.3M | -- | -- | $1.83 | -- |
| 10/23/2025 | Q3 | $789.9M | $804.3M | $1.93 | $1.71 | $0.22 |
| 07/24/2025 | Q2 | $730.1M | $766.2M | $1.82 | $1.54 | $0.28 |
| 04/24/2025 | Q1 | $687.4M | $698.2M | $1.23 | $1.26 | -$0.03 |
| 02/13/2025 | Q4 | $740.9M | $748.5M | $1.77 | $1.73 | $0.05 |
| 10/24/2024 | Q3 | $709.6M | $746.9M | $1.85 | $1.49 | $0.36 |
| 07/25/2024 | Q2 | $728.7M | $702M | $1.51 | $1.73 | -$0.22 |
| 04/25/2024 | Q1 | $671.7M | $695.3M | $1.55 | $1.29 | $0.26 |
| 02/15/2024 | Q4 | $739.5M | $732.1M | $1.83 | $1.78 | $0.04 |
| 10/26/2023 | Q3 | $750.3M | $747.5M | $2.14 | $1.86 | $0.28 |
| 07/27/2023 | Q2 | -- | $754.2M | $2.06 | -- | -- |
| 04/27/2023 | Q1 | -- | $715.9M | $1.85 | -- | -- |
| 02/16/2023 | Q4 | -- | $708.4M | $1.36 | -- | -- |
| 10/27/2022 | Q3 | -- | $686.4M | $1.59 | -- | -- |
| 07/28/2022 | Q2 | -- | $771.6M | $2.49 | -- | -- |
| 04/28/2022 | Q1 | -- | $719.7M | $2.29 | -- | -- |
| 02/17/2022 | Q4 | -- | $729M | $1.93 | -- | -- |
| 10/28/2021 | Q3 | -- | $706.6M | $2.31 | -- | -- |
| 07/29/2021 | Q2 | -- | $724.1M | $2.47 | -- | -- |
| 04/29/2021 | Q1 | -- | $671M | $1.99 | -- | -- |
| 02/18/2021 | Q4 | -- | $580.3M | $1.29 | -- | -- |
| 10/22/2020 | Q3 | -- | $548.3M | $1.09 | -- | -- |
| 07/23/2020 | Q2 | -- | $526.9M | $1.21 | -- | -- |
| 04/23/2020 | Q1 | -- | $491.3M | $0.98 | -- | -- |
| 02/13/2020 | Q4 | -- | $475.1M | $0.84 | -- | -- |
| 10/24/2019 | Q3 | -- | $455.8M | $0.75 | -- | -- |
| 07/25/2019 | Q2 | -- | $469.4M | $0.88 | -- | -- |
| 04/25/2019 | Q1 | -- | $443.3M | $0.74 | -- | -- |
| 02/14/2019 | Q4 | -- | $422.3M | $0.69 | -- | -- |
| 10/25/2018 | Q3 | -- | $431.7M | $0.73 | -- | -- |
| 07/26/2018 | Q2 | -- | $447.8M | $0.75 | -- | -- |
| 04/26/2018 | Q1 | -- | $416.2M | $0.58 | -- | -- |
| 02/15/2018 | Q4 | -- | $416M | -- | -- | -- |
| 10/26/2017 | Q3 | -- | $398.6M | $0.67 | -- | -- |
| 07/27/2017 | Q2 | -- | $397.8M | $0.51 | -- | -- |
| 04/27/2017 | Q1 | -- | $387.8M | $0.81 | -- | -- |
| 02/16/2017 | Q4 | -- | $382.2M | $0.52 | -- | -- |
| 10/27/2016 | Q3 | -- | $376.7M | $0.50 | -- | -- |
| 07/28/2016 | Q2 | -- | $388.1M | $0.60 | -- | -- |
| 04/28/2016 | Q1 | -- | $362.1M | $0.30 | -- | -- |
| 02/18/2016 | Q4 | -- | $359M | $0.45 | -- | -- |
West Pharmaceutical Services, Inc. Earnings Questions
-
How Much did West Pharmaceutical Services, Inc. Generate in Revenue Last Quarter?
West Pharmaceutical Services, Inc. reported $804.3M worth of top line sales in its most recent quarter.
-
Did West Pharmaceutical Services, Inc. Beat Earnings Last Quarter?
West Pharmaceutical Services, Inc. announced earnings per share of $1.93 which represents a beat of analyst forecast a $1.71 per share.
-
Is West Pharmaceutical Services, Inc. Profitable?
West Pharmaceutical Services, Inc. reported $293.5M that represents $4.04 per share over the last quarter.
-
What is the Analyst Consensus for West Pharmaceutical Services, Inc. EPS Next Year?
West Pharmaceutical Services, Inc.'s earnings are forecast to grow from $6.69 per share to $6.63 per share next year representing an increase of 6.28%.
-
When is West Pharmaceutical Services, Inc.'s Earnings Date?
West Pharmaceutical Services, Inc.'s next earnings date is February 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
